HK1245775A1 - 作為丙型肝炎病毒抑制劑的鹽 - Google Patents

作為丙型肝炎病毒抑制劑的鹽

Info

Publication number
HK1245775A1
HK1245775A1 HK18105168.5A HK18105168A HK1245775A1 HK 1245775 A1 HK1245775 A1 HK 1245775A1 HK 18105168 A HK18105168 A HK 18105168A HK 1245775 A1 HK1245775 A1 HK 1245775A1
Authority
HK
Hong Kong
Prior art keywords
hepatitis
salts
virus inhibitors
virus
inhibitors
Prior art date
Application number
HK18105168.5A
Other languages
English (en)
Inventor
任青雲
陳亮
單岳峰
羅慧超
梁金勝
黃建洲
熊金峰
張道俊
張英俊
張健存
Original Assignee
廣東東陽光藥業有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 廣東東陽光藥業有限公司 filed Critical 廣東東陽光藥業有限公司
Publication of HK1245775A1 publication Critical patent/HK1245775A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18105168.5A 2016-08-11 2018-04-20 作為丙型肝炎病毒抑制劑的鹽 HK1245775A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610655907 2016-08-11

Publications (1)

Publication Number Publication Date
HK1245775A1 true HK1245775A1 (zh) 2018-08-31

Family

ID=61162862

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18105168.5A HK1245775A1 (zh) 2016-08-11 2018-04-20 作為丙型肝炎病毒抑制劑的鹽

Country Status (4)

Country Link
CN (1) CN107722014B (zh)
HK (1) HK1245775A1 (zh)
TW (1) TW201805289A (zh)
WO (1) WO2018028634A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110117287B (zh) * 2018-02-07 2020-09-11 广东东阳光药业有限公司 作为丙型肝炎病毒抑制剂的盐

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101580535B (zh) * 2008-05-16 2012-10-03 太景生物科技股份有限公司 丙型肝炎病毒蛋白酶抑制剂
JP2012516351A (ja) * 2009-01-30 2012-07-19 アナコール ファーマシューティカルズ，インコーポレーテッド 化合物
WO2012040242A1 (en) * 2010-09-22 2012-03-29 Intermune, Inc. Substituted proline inhibitors of hepatitis c virus replication
WO2016127859A1 (en) * 2015-02-13 2016-08-18 Sunshine Lake Pharma Co., Ltd. Compounds as hepatitis c inhibitors and uses thereof in medicine

Also Published As

Publication number Publication date
CN107722014A (zh) 2018-02-23
TW201805289A (zh) 2018-02-16
CN107722014B (zh) 2020-07-07
WO2018028634A1 (en) 2018-02-15

Similar Documents

Publication Publication Date Title
IL280459A (en) Phosphoramidates for the treatment of hepatitis B virus
HK1255847A1 (zh) 針對乙型肝炎病毒的疫苗
GB201406608D0 (en) Virus
HK1249046A1 (zh) 治療b型肝炎病毒的方法
HK1249514A1 (zh) C型肝炎病毒聚合酶的抑制劑
HK1257565A1 (zh) 作為htra1抑制劑的新型三氟甲基丙酰胺衍生物
HK1257567A1 (zh) 作為htra1抑制劑的新型二氟酮酰胺衍生物
GB201419572D0 (en) Virus
GB201402169D0 (en) Viral inhibitors
ZA201703114B (en) Long acting pharmaceutical compositions for hepatitis c
ZA201703123B (en) Combination long acting compositions and methods for hepatitis c
HK1245775A1 (zh) 作為丙型肝炎病毒抑制劑的鹽
SG11201610453SA (en) Compounds for inhibiting hepatitis c virus, pharmaceutical compositions and uses thereof
PL3131890T3 (pl) Związki do leczenia zakażeń wirusowych
EP3445367A4 (en) INHIBITORS OF HEPATITIS C VIRUS
GB201600380D0 (en) Modified virus
GB201522013D0 (en) Virus
GB201516936D0 (en) Virus
GB201507419D0 (en) Virus
ES1133530Y (es) Chupete perfeccionado
GB201408266D0 (en) Liver infection
TH1501004918A (th) สารประกอบเอไมด์สำหรับการบำบัด hiv
GB201406470D0 (en) Virus
GB201403582D0 (en) Virus